13.39
price down icon1.11%   -0.15
after-market 시간 외 거래: 13.39
loading

Edgewise Therapeutics Inc 주식(EWTX)의 최신 뉴스

pulisher
Jul 21, 2025

What drives Edgewise Therapeutics Inc. stock priceMassive wealth growth - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Edgewise Therapeutics Inc. Stock Analysis and ForecastAccelerated investment success - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

What analysts say about Edgewise Therapeutics Inc. stockExplosive trading growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Is Edgewise Therapeutics Inc. a good long term investmentUnstoppable trading performance - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Jul 19, 2025
pulisher
Jul 18, 2025

When is the best time to buy Edgewise Therapeutics Inc. stockSmart Growth Low Risk Picks - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - cnhinews.com

Jul 17, 2025
pulisher
Jul 16, 2025

why edgewise therapeutics inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Edgewise Therapeutics Inc. stock price move sharplyQuick Profit Idea Stream - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Edgewise Therapeutics Inc. stock performs during market volatilityShort Squeeze Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Edgewise Therapeutics Inc. stock attracts strong analyst attentionSmart Money Signals - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 7.9%Time to Buy? - MarketBeat

Jul 12, 2025
pulisher
Jul 08, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Jul 08, 2025
pulisher
Jul 07, 2025

Edgewise Therapeutics Reports Positive Results for Muscular Dystrophy Treatment - MSN

Jul 07, 2025
pulisher
Jul 05, 2025

(EWTX) Trading Report - news.stocktradersdaily.com

Jul 05, 2025
pulisher
Jul 03, 2025

User - FinancialContent

Jul 03, 2025
pulisher
Jul 01, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Now Covered by HC Wainwright - Defense World

Jul 01, 2025
pulisher
Jun 30, 2025

HC Wainwright Initiates Edgewise Therapeutics With Buy Rating, $42 Price Target - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Edgewise Therapeutics (EWTX) Initiated with Buy Rating by HC Wainwright | EWTX Stock News - GuruFocus

Jun 30, 2025
pulisher
Jun 29, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap DownHere's Why - MarketBeat

Jun 29, 2025
pulisher
Jun 28, 2025

Analysts Offer Insights on Healthcare Companies: BeiGene (ONC), Vertex Pharmaceuticals (VRTX) and Edgewise Therapeutics (EWTX) - The Globe and Mail

Jun 28, 2025
pulisher
Jun 27, 2025

Edgewise Therapeutics Shares Drop After FDA Withholds Accelerated Approval for Muscle Disorder Drug - MSN

Jun 27, 2025
pulisher
Jun 27, 2025

Edgewise Therapeutics' Regulatory Setback: A Cautionary Tale for Biotech Investors - AInvest

Jun 27, 2025
pulisher
Jun 26, 2025

Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies - WV News

Jun 26, 2025
pulisher
Jun 26, 2025

Edgewise Therapeutics stock falls after FDA deems data insufficient for accelerated approval - Investing.com UK

Jun 26, 2025
pulisher
Jun 18, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.8%Here's What Happened - MarketBeat

Jun 18, 2025
pulisher
Jun 18, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stake Boosted by GAMMA Investing LLC - MarketBeat

Jun 18, 2025
pulisher
Jun 17, 2025

Rhumbline Advisers Purchases 6,440 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Jun 17, 2025
pulisher
Jun 14, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $39.78 Average PT from Analysts - MarketBeat

Jun 14, 2025
pulisher
Jun 13, 2025

Enliven to sell $200M in stock after positive drug trial - BizWest

Jun 13, 2025
pulisher
Jun 10, 2025

Does Edgewise Therapeutics (EWTX) Have the Potential to Rally 174.68% as Wall Street Analysts Expect? - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Transcript : Edgewise Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 03 - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Bank of America Corp DE Has $1.31 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 09, 2025
pulisher
Jun 08, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Receives "Outperform" Rating from Royal Bank of Canada - MarketBeat

Jun 08, 2025
pulisher
Jun 07, 2025

Ameriprise Financial Inc. Purchases Shares of 22,584 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 07, 2025
pulisher
Jun 07, 2025

Royal Bank of Canada Reaffirms Outperform Rating for Edgewise Therapeutics (NASDAQ:EWTX) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Bank of America Corp DE Decreases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Edgewise Therapeutics (EWTX) Receives Reaffirmed 'Outperform' Ra - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

RBC Capital maintains outperform rating on Edgewise Therapeutics stock By Investing.com - Investing.com India

Jun 05, 2025
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):